Retrospective Cohort Study
Copyright ©The Author(s) 2022.
World J Gastrointest Endosc. Nov 16, 2022; 14(11): 672-683
Published online Nov 16, 2022. doi: 10.4253/wjge.v14.i11.672
Table 2 Comparison of outcomes between eligible procedures performed with and without trainees

With trainees, n = 370
Without trainees, n = 968
P value
OR (95%CI)
Patient age, median (IQR)64 (57-72)64 (57-72)0.83-
Patient gender (male %)53.5 (n = 198)47.4 (n = 463)0.06-
Cancer detection rate (%)4.1 (n = 15)3.3 (n = 32)0.511.24 (0.66-2.31)
CSPDR (%)41.4 (n = 147)42.7 (n = 400)0.670.95 (0.74-1.21)
ADR (%)38.9 (n = 138)40.4 (n = 378)0.620.94 (0.73-1.21)
SLDR (%)4.8 (n = 17)6.3 (n = 59)0.300.74 (0.43-1.30)